生命科学资讯
生物技术与制药领域的最新动态
FDA issues draft guidance to reduce primate testing for certain antibodies
Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter
CDER head Richard Pazdur set to retire shortly after appointment
FDA to remove some monkey testing from monoclonal antibody development
Richard Pazdur, FDA drug czar, to retire from agency
2025年12月2日赛默飞世尔科技(TMO)股价动态：价格走势、汇丰银行上调评级、新债务协议及2026-2030年预测 - ts2.tech
Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts - ts2.tech
Tech emerges as a new frontier for digital therapeutics
FDA details plan to scale back animal tests for some antibody drugs
Hightide’s HTD-1801 outperforms Farxiga in type 2 diabetes
Subcutaneous biologics maker Bao Pharma prices $128M IPO
ARCH, Parker Institute build next big oncology bet with suite of programs and startup acquisition
Top drug regulator Rick Pazdur plans to leave FDA
古菌转录因子连接原核与真核调控范式
An archaeal transcription factor bridges prokaryotic and eukaryotic regulatory paradigms
Imvax向FDA提交脑癌细胞疗法，押注生存率突破将盖过主要终点未达预期。
Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss
Tiziana将IL-6药物分拆至新公司，称大型药企对该疗法模式兴趣浓厚
Tiziana to spin out IL-6 drug into new company, citing Big Pharma's interest in modality
Novocure任命新CEO，现任首席执行长任职不足一年即被替换。
Novocure promotes new CEO, replacing current chief after less than a year
罗氏即时百日咳检测获美欧批准，病例激增之际迎来绿灯。
Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge
News in brief
摩根士丹利开始覆盖安捷伦科技（A）——GuruFocus
Morgan Stanley Initiates Coverage on Agilent Technologies (A) wi - GuruFocus